Nantes, France

Yann Godet

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Chu Nantes, National Institute of Health and Medical Research, The University of Nantes. Active years: 2013-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yann Godet. Retrieved from https://idiyas.com/inventor/yann-godet

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 50.0

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Nantes Cedex 1, FR (2013)
  • Nantes Cedex, FR (2015)

Company Filing History:


Years Active: 2013-2015

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Yann Godet: Innovator in Melanoma Research

Introduction

Yann Godet is a notable inventor based in Nantes, France, recognized for his contributions to the field of melanoma research. With a total of 2 patents to his name, he has made significant strides in developing novel treatments for melanoma, a serious form of skin cancer.

Latest Patents

Yann Godet's latest patents include innovative melanoma antigen peptides and specific T lymphocytes directed to these peptides. These inventions focus on the use of these peptides for treating melanoma, showcasing his commitment to advancing medical science and improving patient outcomes.

Career Highlights

Throughout his career, Yann has worked with esteemed institutions such as the Institut National de la Santé et de la Recherche Médicale and the Université de Nantes. His work in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Yann has collaborated with notable colleagues, including Nathalie Labarriere and Agnes Moreau-Aubry, further enhancing the impact of his research through teamwork and shared expertise.

Conclusion

Yann Godet's innovative work in melanoma research and his dedication to developing effective treatments highlight his importance in the medical field. His contributions continue to inspire advancements in cancer therapy and patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…